MARC Record from marc_columbia

LEADER: 06062fam a2200445 a 4500
001 4059382
005 20221027025824.0
008 980722t19991999paua b 001 0 eng c
010 $a 98034773
020 $a0443075921
035 $a(OCoLC)39625387
035 $a(OCoLC)ocm39625387
035 $9APC2806HS
035 $a(NNC)4059382
035 $a4059382
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB-B
050 00 $aRC607.A26$bA3675 1999
060 10 $aWC 503.2$bA2885 1999
082 00 $a616.97/9206$221
245 00 $aAIDS therapy /$c[edited by] Raphael Dolin, Henry Masur, Michael S. Saag.
260 $aPhiladelphia :$bChurchill Livingstone,$c[1999], ©1999.
300 $axv, 864 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gSect. I.$tDiagnosis of HIV Infection.$gCh. 1.$tEstablishing the Diagnosis of HIV Infection /$rMark Holodniy --$gSect. II.$tAntiretroviral Therapy.$gCh. 2.$tZidovudine /$rMargaret A. Fischl.$gCh. 3.$tDidanosine /$rRaphael Dolin.$gCh. 4.$tZalcitabine /$rJohn A. Bartlett.$gCh. 5.$tStavudine /$rAndrew T. Pavia.$gCh. 6.$tLamivudine /$rJoseph J. Eron, Jr.$gCh. 7.$tNevirapine /$rJulio S. G. Montaner and Joep M. A. Lange.$gCh. 8.$tDelavirdine /$rLisa M. Demeter and Richard C. Reichman.$gCh. 9.$tAbacavir (1592U89) /$rVictoria A. Johnson.$gCh. 10.$tEfavirenz /$rDouglas L. Mayers.$gCh. 11.$tSaquinavir /$rAnn C. Collier and Kathleen E. Squires.$gCh. 12.$tRitonavir /$rSven A. Danner.$gCh. 13.$tIndinavir /$rRoy Gulick.$gCh. 14.$tNelfinavir /$rRichard H. Haubrich and Diane Havlir.$gCh. 15.$tAmprenavir /$rRobert L. Murphy and Michael Kilby.$gCh. 16.$tAdefovir Dipivoxil /$rCraig J. Hoesley and Michael S. Saag --$gSect. III.$tImmune-Based Therapies.
505 80 $gCh. 17.$tImmune-Based Therapies in the Management of HIV-Infected Patients /$rJoseph A. Kovacs --$gSect. IV.$tOther Therapies, Including Alternative Therapies.$gCh. 18.$tAlternative Therapies /$rDonald I. Abrams --$gSect. V.$tStrategies for Managing Antiretroviral Therapies.$gCh. 19.$tEarly Intervention: Acute HIV Infection Syndrome /$rJames O. Kahn, Frederick M. Hecht and Margaret A. Chesney [et al.].$gCh. 20.$tPostexposure Management /$rDenise M. Cardo, Dawn K. Smith and David M. Bell.$gCh. 21.$tInitiation of Therapy /$rRoger T. Inouye and Scott M. Hammer.$gCh. 22.$tManagement of Antiretroviral Therapy Failure /$rMichael S. Saag.$gCh. 23.$tManaging Pregnant Patients /$rD. Heather Watts --$gSect. VI.$tDiagnosis, Therapy, and Prevention of Opportunistic Processes.$gCh. 24.$tPneumocystosis /$rHenry Masur.$gCh. 25.$tToxoplasmosis /$rHenry W. Murray.$gCh. 26.$tCryptosporidium, Isospora, and Cyclospora Infections /$rTimothy P. Flanigan.$gCh. 27.$tMicrosporidiosis /$rLouis M. Weiss.
505 80 $gCh. 28.$tEnteric Bacterial Diseases /$rAnne Rompalo and Thomas C. Quinn.$gCh. 29.$tMycobacterium tuberculosis /$rFred Gordin.$gCh. 30.$tMycobacterium avium Complex and Other Atypical Mycobacterial Infections /$rConstance A. Benson.$gCh. 31.$tBartonellosis /$rJane E. Koehler.$gCh. 32.$tCryptococcosis /$rWilliam G. Powderly.$gCh. 33.$tHistoplasmosis /$rJoseph Wheat.$gCh. 34.$tCoccidioidomycosis /$rNeil M. Ampel.$gCh. 35.$tCandidiasis /$rCarl J. Fichtenbaum.$gCh. 36.$tMycoses Caused by Moulds /$rJohn R. Graybill and Thomas F. Patterson.$gCh. 37.$tCytomegalovirus Disease /$rMark A. Jacobson.$gCh. 38.$tVaricella-Zoster Virus Infections /$rJohn W. Gnann, Jr.$gCh. 39.$tHerpes Simplex Virus Infections /$rJohn C. Pottage, Jr. and Harold A. Kessler.$gCh. 40.$tEpstein-Barr Virus Disease /$rThomas G. Evans.$gCh. 41.$tHuman Herpesvirus -6 and -7 Infections /$rDavid W. Kimberlin and John W. Gnann, Jr.$gCh. 42.$tViral Hepatitis /$rAdrian M. Di Bisceglie.
505 80 $gCh. 43.$tSexually Transmitted Human Papillomavirus Infection /$rWilliam Bonnez.$gCh. 44.$tJC Virus Neurologic Infection /$rColin D. Hall.$gCh. 45.$tSexually Transmitted Diseases /$rEdward W. Hook III.$gCh. 46.$tKaposi Sarcoma /$rSusan E. Krown.$gCh. 47.$tNon-Hodgkin Lymphoma /$rMansoor N. Saleh and David T. Scadden --$gSect. VII.$tApproach to Specific Syndromes.$gCh. 48.$tWasting Syndrome /$rJamie H. Von Roenn and Kathleen Mulligan.$gCh. 49.$tNeurologic Disease /$rRichard W. Price.$gCh. 50.$tDermatologic Disease /$rJeffrey P. Callen and Clay J. Cockerell.$gCh. 51.$tOropharyngeal Disease /$rDeborah Greenspan, Penelope J. Shirlaw and John S. Greenspan.$gCh. 52.$tOphthalmologic Disease /$rDouglas A. Jabs.$gCh. 53.$tHematologic Disease /$rRonald Mitsuyasu.$gCh. 54.$tCardiac Disease /$rAmy Giantris and Steven E. Lipshultz.$gCh. 55.$tPulmonary Disease /$rJudith Feinberg and Robert P. Baughman.$gCh. 56.$tRenal Disease /$rPaul L. Kimmel.$gCh. 57.$tEndocrine Disease /$rJoan C. Lo and Morris Schambelan.
505 80 $gCh. 58.$tGastrointestinal Disease /$rC. Mel Wilcox and Klaus E. Monkemuller.$gCh. 59.$tHepatic and Hepatobiliary Disease /$rDouglas T. Dieterich and Michael A. Poles --$gSect. VIII.$tDrug Administration and Interactions.$gCh. 60.$tDrug Administration and Interactions /$rCharles Flexner and Stephen C. Piscitelli.$gCh. 61.$tAIDS-Related Medications /$rStephen C. Piscitelli --$gApp. A.$tHIV-Related Internet Resources /$rBill Barrick --$gApp. B.$tAntiretroviral Adult Dosage Guidelines /$rAlice Pau.
650 0 $aAIDS (Disease)$xTreatment.
650 0 $aAIDS (Disease)$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh2009114517
650 0 $aAntiviral agents.$0http://id.loc.gov/authorities/subjects/sh85005787
650 0 $aOpportunistic infections$xTreatment.
650 0 $aAIDS (Disease)$xComplications$xTreatment.
650 12 $aAcquired Immunodeficiency Syndrome$xtherapy.$0https://id.nlm.nih.gov/mesh/D000163Q000628
700 1 $aDolin, Raphael.$0http://id.loc.gov/authorities/names/n95800067
700 1 $aMasur, Henry.$0http://id.loc.gov/authorities/names/n86105086
700 1 $aSaag, Michael S.$0http://id.loc.gov/authorities/names/n94803626
852 00 $boff,hsl$hRC607.A26$iA3675 1999 Q